4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 99
+0.15
+1.3838%
$
611.63M Market Cap
- P/E Ratio
- Div Yield
598,500 Volume
-3.06 Eps
$ 10.84
Previous Close 
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4D Molecular Therapeutics, Inc. (FDMT) Statistics
Valuation metrics
Market Cap 611.63M
Enterprise value 522.56M
Trailing P/E (ttm) -4.13
Forward P/E -
PEG ratio -0.94
Price/Sales (ttm) 6.51
Price/Book (mrq) 1.66
Enterprise Value/Revenue 5.92
Enterprise Value/EBITDA -3.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 488.16K
Average volume (90 days) 770.37K
Price summary
52-Week low 4.14
52-Week high 14
Beta -
50-Day moving average 10.57
200-Day moving average 9.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.82%
Operating margin -2.03%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 9.34%
Book value per share (mrq) 6.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
